Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients.
Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis.
Genome-wide significant association with seven novel multiple sclerosis risk loci.
Oligodendroglial defects during quakingviable cerebellar development.
Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Functional adaptation of presynaptic chemokine receptors in EAE mouse central nervous system.
Vitamin d: shining a light on clinical and sex specific effects in multiple sclerosis?
Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013.
Working memory performance of early MS patients correlates inversely with modularity increases in resting state functional connectivity networks.
Requirement for safety monitoring for approved MS therapies - An overview.
SOX2+ Cell Population from Normal Human Brain White Matter Is Able to Generate Mature Oligodendrocytes.
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
Virtual Sensory Feedback for Gait Improvement in Neurological Patients.
Oligodendroglial Development: New Roles for Chromatin Accessibility.
Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.
A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Prompt diagnosis of multiple sclerosis should be routine, says NICE.
αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features.
Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy.
CNS accumulation of regulatory B cells is VLA-4-dependent.
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Glucocorticoid-induced apoptosis in animal models of multiple sclerosis.
Pages
« first
‹ previous
…
622
623
624
625
626
627
628
629
630
…
next ›
last »